BioGaia invests further in MetaboGen
On April 6, 2018, BioGaia became the majority shareholder in MetaboGen with a 62 percent stake. BioGaia has now, after the set milestones have been achieved, decided to further extend its holding, resulting in a shareholding of 92 percent of the shares in MetaboGen. The acquisition value of the additional 30 percent amounts to approximately SEK 27.8 million.BioGaia will also acquire the remaining eight percent in the company within a three-year period. The additional purchase price can amount to a maximum of SEK 12 million depending on how many milestones are achieved. BioGaia’s previous